Reviva Pharmaceuticals Holdings RVPH
OTC RVPH
$0.34 +0.00 (+0.00%)
At close: Nov 13, 2026 · 4:00 PM EST

Reviva Pharmaceuticals Holdings (RVPH) Net Long-Term Debt Issued (Repaid) (2018 - 2020)

Updated

Reviva Pharmaceuticals Holdings' Non-Current Debt was $1.98 million in Q3 2020, up 38.6% from the prior quarter.

Analysis

Reviva Pharmaceuticals Holdings (RVPH) Net Long-Term Debt Issued (Repaid) (2018 - 2020) Analysis & Trends

At the end of FY2019, Non-Current Debt at Reviva Pharmaceuticals Holdings came in at $750,000.

  • Per Business Quant data, RVPH's Non-Current Debt in the three quarters before Q3 2020 was $1.43 million (Q2 2020), $1.13 million (Q1 2020) and $750,000 (Q4 2019).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net LT Debt (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn -1.00 Mn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 9.98 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn -
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 4.91 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn -3.05 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn -19.00 Mn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn -
10 Reviva Pharmaceuticals Holdings 4.46 Mn -82.75 Mn - -
Historic Data

Historic Data

Download Data
DateValue
May 31, 2020 375,000.00
Nov 30, 2019 363,436.00
Feb 28, 2019 -363,436.00
May 31, 2018 56,045.00
API Access

Reviva Pharmaceuticals Holdings Net Long-Term Debt Issued (Repaid) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=RVPH&period=max&api_key=YOUR_API_KEY